Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Healthcare Ishares ETF (IYH)

US Healthcare Ishares ETF (IYH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 3,069,010,600
  • Shares Outstanding, K 10,650
  • 60-Month Beta 0.77
Trade IYH with:
  • Price/Earnings ttm 31.24
  • Annual Dividend & Yield 2.84 (0.98%)
  • Most Recent Dividend 0.530 on 06/10/21
  • Management Fee 0.43%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 17.78%
  • Historical Volatility 8.32%
  • IV Percentile 58%
  • IV Rank 46.45%
  • IV High 30.77% on 10/30/20
  • IV Low 6.52% on 04/19/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
284.77 +0.09%
on 09/20/21
296.68 -3.92%
on 09/03/21
-8.41 (-2.87%)
since 08/20/21
3-Month
267.07 +6.73%
on 06/21/21
296.68 -3.92%
on 09/03/21
+17.79 (+6.66%)
since 06/18/21
52-Week
216.85 +31.45%
on 09/24/20
296.68 -3.92%
on 09/03/21
+57.81 (+25.44%)
since 09/18/20

Most Recent Stories

More News
Climb the "Wall of Worry" With These ETFs

A myriad of hurdles has continued to kept investors jittery and resulted in a flight to defensive sectors like utilities, real estate, healthcare and consumer staples.

VNQ : 105.55 (-0.80%)
IYH : 284.51 (-1.23%)
XLU : 65.72 (-1.02%)
VDC : 183.03 (-1.18%)
Time for Pharma and Healthcare ETFs?

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

MRNA : 422.87 (-1.67%)
IYH : 284.51 (-1.23%)
BBH : 214.27 (-1.67%)
FXH : 123.86 (-1.31%)
IEIH : 35.90 (-1.09%)
2 Sector ETFs Hovering Around All-Time Highs

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

NETL : 30.48 (-0.53%)
IYH : 284.51 (-1.23%)
BBH : 214.27 (-1.67%)
FXH : 123.86 (-1.31%)
RWR : 107.87 (-1.09%)
REZ : 88.06 (-0.08%)
NURE : 35.76 (-0.86%)
IEIH : 35.90 (-1.09%)
Healthcare ETFs in Focus as Q2 Earnings Unfold

The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.

BMY : 60.52 (-1.29%)
UNH : 412.39 (-1.85%)
JNJ : 163.58 (-0.71%)
PFE : 44.04 (+0.34%)
MRK : 71.80 (+0.17%)
AMGN : 215.05 (-1.97%)
GILD : 70.87 (-1.03%)
TMO : 588.73 (-1.35%)
ABBV : 106.19 (-1.43%)
XLV : 130.90 (-1.58%)
IYH : 284.51 (-1.23%)
VHT : 255.41 (-1.31%)
FHLC : 65.60 (-1.35%)
JNJ Beats on Q2 Earnings, Ups View: ETFs to Buy

The company recorded 164 million in COVID-19 vaccine sales in the second quarter, up 64% from the first, and aims to fetch $2.5 billion in sales by the end of the year.

JNJ : 163.58 (-0.71%)
XLV : 130.90 (-1.58%)
IYH : 284.51 (-1.23%)
VHT : 255.41 (-1.31%)
IHE : 184.62 (-0.94%)
IEIH : 35.90 (-1.09%)
UnitedHealth's Solid Q2 Earnings Put These ETFs in Focus

UnitedHealth reported better-than-expected second-quarter 2021 results, breezing past the Zacks Consensus Estimate for both earnings and revenues.

UNH : 412.39 (-1.85%)
XLV : 130.90 (-1.58%)
IYH : 284.51 (-1.23%)
VHT : 255.41 (-1.31%)
IHF : 263.78 (-1.85%)
IEHS : 43.42 (-1.59%)
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results

Johnson & Johnson (JNJ) continued its long streak of earnings beat and outpaced revenue estimates. However, the company tightened its full-year guidance.

JNJ : 163.58 (-0.71%)
XLV : 130.90 (-1.58%)
VHT : 255.41 (-1.31%)
IYH : 284.51 (-1.23%)
IHE : 184.62 (-0.94%)
IEIH : 35.90 (-1.09%)
Healthcare ETFs to Gain on UnitedHealth's Strong Q1 Earnings

UnitedHealth Group (UNH) reported better-than-expected first-quarter 2021 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full-year earnings...

UNH : 412.39 (-1.85%)
XLV : 130.90 (-1.58%)
VHT : 255.41 (-1.31%)
IYH : 284.51 (-1.23%)
IHF : 263.78 (-1.85%)
IEHS : 43.42 (-1.59%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 163.58 (-0.71%)
XLV : 130.90 (-1.58%)
IYH : 284.51 (-1.23%)
IHE : 184.62 (-0.94%)
FTXH : 25.47 (-0.46%)
IEIH : 35.90 (-1.09%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 163.58 (-0.71%)
XLV : 130.90 (-1.58%)
IYH : 284.51 (-1.23%)
IHE : 184.62 (-0.94%)
FTXH : 25.47 (-0.46%)
IEIH : 35.90 (-1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Healthcare ETF seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The Fund seeks investment results that correspond to the performance of the Dow Jones U.S. Health Care Index. The Fund will concentrate its investments in the healthcare...

See More

Key Turning Points

3rd Resistance Point 290.69
2nd Resistance Point 289.43
1st Resistance Point 288.75
Last Price 284.51
1st Support Level 286.81
2nd Support Level 285.55
3rd Support Level 284.87

See More

52-Week High 296.68
Last Price 284.51
Fibonacci 61.8% 266.18
Fibonacci 50% 256.76
Fibonacci 38.2% 247.34
52-Week Low 216.85

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar